Edit search
Pharmacokinetics and safety of 14 days intravenous voriconaz…
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
Article, Chapter
Authors: R.J.M. Bruggemann
Publication: Journal of Antimicrobial Chemotherapy, Volume:65, Issue:1, Page(s):107
Published: 2010
ISSN: 0305-7453
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item